Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: The Next Pot of Gold in 2022?

(Photo of mineralization from NFGC-21-195 approximately 285m down hole depth and Right: NFGC-21-202 approximately 146m down hole depth. Image via New Found Gold Corp.) We have waited three long years for this: St. Patrick’s Day is back, and so are al...
Stockhouse Editorial | March 15, 2022 |

The Psychedelic Opportunity You Need to Know About

When Stockhouse Editorial last caught up with Toronto-based CYBIN Inc. ( N.CYBN , OTC: CYBN , Forum ) back in September 2020 , the psychedelic life sciences company was just going public…and to much fanfare. Cybin is a life sciences company that views psychedelic subst...
Dave Jackson | October 19, 2021 |

AI & Humor in the Workplace … A Laughing Matter?

We have all worried about “robots taking our jobs”, but working in a creative field, I’ve always had a high-and-mighty belief that no mere machine could do what I do … until they could. Running a certain set of parameters through an ar...
According to published reports | September 1, 2021 |

A ‘Barrier’ to Better Health

(Click image to play podcast) The blood-brain barrier plays an essential role in protecting the brain from blood-borne disease. But is also one of medicine’s great paradoxes – a system designed to protect the most sensitive region of the body bu...
Dave Jackson | September 29, 2020 |

Genius Brands Shares Rise 15% on Planned Launch of the New 'Kartoon Channel!'

Genius Brands International shares traded higher after the company reported that on Monday, June 15, it will be launching the new "Kartoon Channel!", which will be available in over 100 million U.S. television households and on 200 million mobile devices. Geni...
Streetwise Reports | June 15, 2020 |

Huge Unemployment Is Coming. Will It Push Gold Prices Up?

On Thursday, the initial jobless claims rocketed to almost 3.3 million. Quite an unimaginable number. What does it imply for the US economy and the gold market? One of the Most Scariest Things You Will See This Week Would you like to see something scary? I guess not, b...
Arkadiusz Sieron | March 31, 2020 |

The Company That’s Redefining the Staffing Industry

Get to know capital market moguls, mavens and management teams in a more relaxed setting. PROFIT! episodes open with fun, rapid-fire questions, setting the tone for a more informal one-on-one session. You won’t want to miss our weekly releases f...
Stockhouse Editorial | March 9, 2020 |

Buzz on the Bullboards: Stocks Poised for Coronavirus Recovery?

Where do small-cap investors look when the markets are down? Go back a few weeks or months and you’ll see that the COVID 19 coronavirus was being brushed off by Wall Street. Fast forward to last week, and it seems like the other shoe has finally dropped, se...
Omri Wallach | February 26, 2020 |

Baudax Shares Rise as FDA Approves NDA for Its Non-Opioid Pain Medication

Shares of Baudax Bio traded more than 20% higher and set a new 52-week high price after reporting that the FDA approved the company's non-opioid ANJESO™ drug for management of moderate to severe pain. Specialty pharmaceutical company Baudax Bio Inc. (BXRX:N...
Streetwise Reports | February 24, 2020 |

Cashing in the Exploding Esports and Esports Betting Markets

Get to know capital market moguls, mavens and management teams in a more relaxed setting. Episodes open with fun, rapid-fire questions, setting the tone for a more informal one-on-one session. You won’t want to miss our weekly releases featuring thought ...
Cindy Broad | February 17, 2020 |
1 2 3 4